Not Signed In - Teva Announces Tentative Approval Of Sumatriptan Succinate Tablets
Fri, 01 Dec 2006 08:00 AM EST
... Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Sumatriptan Succinate Tablets, 25 mg, 50 mg and 100 mg. Final approval is expected upon expiry of patent protection for the brand product in February 2009. [click link for full article] ...
Related Topics
- Doxylamine
- Carbinoxamine and Pseudoephedrine Tablets
- Vaccine Testing & Approval
- Frovatriptan
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Sumatriptan
- Cyanocobalamin Tablets
- Chlorpheniramine, Pseudoephedrine and Hydrocodone Tablets
- Guaifenesin and Dextromethorphan
- Thiabendazole Tablets
- Haloperidol Tablets
- Neostigmine Tablets
- Carbetapentane, Phenylephrine, and Pyrilamine
- Ergoloid Mesylates Sublingual Tablets
- Desmopressin Tablets
- Nystatin Tablets
- Isosorbide Dinitrate, Tablets or Extended-Release Tablets or Capsules
- Tarceva
- Gatifloxacin tablets
- Sumatriptan Injection
email this page
print this page
bookmark this page
feedback on this page
